NL
DE
7 April 2017
More than 30 pathology departments in the Netherlands participate in this multi-center study. Via a close collaboration between pathology departments and treating physicians (medical oncologists, pulmonary oncologists) we aim to build a nationwide infrastructure to implement and evaluate innovative genomic cancer diagnostic opportunities in clinical cancer care. In order to achieve this goal predictive tumor genetic diagnostics will be optimized, a national expert network will be built, and the clinical utility will be studied. Targeted therapies are a breakthrough in cancer treatment. The effectiveness of these therapies often depends on specific molecular tumor profiles. It is a challenge to predict which patients may benefit from these precision medicines. Therefore the PATH project was initiated: Predictive Analysis for THerapy.
Lieneke Steeghs
Targeted therapies are a breakthrough in cancer treatment. The effectiveness of these therapies often depends on specific molecular tumor profiles. It is a challenge to predict which patients may benefit from these precision medicines. Therefore the PATH project was initiated: Predictive Analysis for THerapy.
More than 30 pathology departments in the Netherlands participate in this multi-center study. Via a close collaboration between pathology departments and treating physicians (medical oncologists, pulmonary oncologists) we aim to build a nationwide infrastructure to implement and evaluate innovative genomic cancer diagnostic opportunities in clinical cancer care. In order to achieve this goal predictive tumor genetic diagnostics will be optimized, a national expert network will be built, and the clinical utility will be studied. Targeted therapies are a breakthrough in cancer treatment. The effectiveness of these therapies often depends on specific molecular tumor profiles. It is a challenge to predict which patients may benefit from these precision medicines. Therefore the PATH project was initiated: Predictive Analysis for THerapy.
Lieneke Steeghs
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
7 May 2020 In a commentary in Lancet Oncology Iris Nagtegaal, theme Tumors of the digestive tract, published, together with Thijs Merkx, as head of the IKNL, the latest data that illustrate the impact of the pandemic on the detection of new cancer patients. read more
Awarded KWF grants for Radboudumc researchers
18 December 2019 KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work. read more
Francesco Ciompi and Jeroen van der Laak have been awarded a KWF grant
28 March 2019 Francesco Ciompi and Jeroen van der Laak have been awarded a KWF grant of € 200K with € 150K for Radboudumc for the PROACTING project (PRedicting neOAdjuvant Chemotherapy Treatment response with deeplearnING). read more
Lieneke Steeghs about the PATH project: Predictive Analysis for Therapy
22 March 2019 Read here the article 'PATH makes predictive molecular diagnostics in cancer unambiguous', of Lieneke Steeghs, theme Tumors of the digestive tract, that was published on the website of ZonMw. read more
Valentine’s day spectacle at the Radboud Research Rounds
21 February 2019 This year’s Valentine’s day in the Radboudumc was focused on the RRR of the Tumors of the Digestive Tract. In the biannual Paper Award session the big prize went to Daniel Garza from the Center for Molecular and Biomolecular Informatics, for his paper on “the environmental metabolome”. read more
